Skip to main content
. 2016 Jan 22;10(5):516–524. doi: 10.1093/ecco-jcc/jjw008

Figure 4.

Figure 4.

Panel A: Antibodies to infliximab [ng/ml] before start of azathioprine treatment at Month [M] 0 (mean: 320 [200–600]) and at 6 months (M6; mean: 60 [10–500]; p = 0.01) in 13 infliximab-treated patients. Panel B: Crohn’s Disease Activity Index [CDAI] scores before start of azathioprine treatment at Month [M] 0 and at 6 months [M6] in 13 infliximab-treated patients.